Results 151 to 160 of about 30,764 (208)

Paradoxical clade- and age-specific vaccine effectiveness during the 2018/19 influenza A(H3N2) epidemic in Canada: potential imprint-regulated effect of vaccine (I-REV)

, 2019
Danuta M. Skowronski, Suzana Sabaiduc, Siobhan Leir, Caren Rose, Macy Zou, Michelle Murti, James A. Dickinson, Romy Olsha, Jonathan B. Gubbay, Matthew A. Croxen, Hugues Charest, Nathalie Bastien, Yan Li, Agatha N. Jassem, Mel Krajden, Gaston De Serres   +15 more
openalex   +1 more source

Trivalent influenza vaccine in patients on haemodialysis: Impaired seroresponse with differences for A-H3N2 and A-H1N1 vaccine components

, 1987
W.E.P. Beyer, Dennis Versluis, P. Kramer, Ph.P.M.N. Diderich, Willem Weimar, N. Masurel   +5 more
openalex   +2 more sources

Comparison of the virologic and immunologic responses of volunteers to live avian-human influenza A H3N2 reassortant virus vaccines derived from two different avian influenza virus donors [PDF]

, 1989
M L Clements, S D Sears, K Christina, Brian R. Murphy, M H Snyder   +4 more
openalex   +1 more source

Natural infection and vaccination with influenza A (H3N2).

, 1977
Previous assessments of the efficacy of inactivated influenza A vaccines have met with only limited success. Low challenge rates, lack of a stable population and inadequate information on vaccine and control groups have made results difficult to interpret.
openaire   +1 more source

Clinical Serum-Anchored Computational Design Pipeline for a Broad-Spectrum Influenza Multi-Epitope mRNA Vaccine. [PDF]

Biology (Basel)
Yuan L, Ouyang Z, Zhao Y, Bi R, Wu Y, Li X, Li Y, Song J, Li W, Yan M, Wen S, Luo H, Bai T, Shu Y, Chen Y.   +14 more
europepmc   +1 more source

Baloxavir susceptibility of seasonal influenza viruses during the first seven seasons of clinical use in Japan, 2017/18 to 2023/24. [PDF]

Euro Surveill
Takashita E, Fujisaki S, Morita H, Nagata S, Miura H, Kishida N, Nakamura K, Shirakura M, Sato A, Akimoto M, Sugawara H, Mitamura K, Abe T, Ichikawa M, Yamazaki M, Watanabe S, Odagiri T, Hasegawa H, Influenza Virus Surveillance Group of Japan.   +18 more
europepmc   +1 more source

Molecular epidemiology and phylogenetic analysis of influenza viruses A (H3N2) and B/Victoria during the COVID-19 pandemic in Guangdong, China [PDF]

Zhiqi Zeng, Yong Liu, Wenxiang Jin, Jingyi Liang, Jinbin Chen, Ruihan Chen, Qianying Li, Wenda Guan, Lixi Liang, Qiubao Wu, Yuanfang Lai, Xiaoyan Deng, Zhengshi Lin, Chitin Hon, Zifeng Yang   +14 more
openalex   +1 more source

High-throughput neutralization measurements correlate strongly with evolutionary success of human influenza strains. [PDF]

Elife
Kikawa C, Loes AN, Huddleston J, Figgins MD, Steinberg P, Griffiths T, Drapeau EM, Peck H, Barr I, Englund JA, Hensley SE, Bedford T, Bloom JD.   +12 more
europepmc   +1 more source

Triple reassortant swine influenza A (H3N2) virus in waterfowl.

Emerging infectious diseases, 2010
Ramakrishnan, Muthannan A., Wang, Ping, Abin, Martha, Yang, My, Goyal, Sagar M., Gramer, Marie R., Redig, Patrick, Fuhrman, Monte W., Sreevatsan, Srinand   +8 more
openaire   +2 more sources

Assessment of immunogenicity and protection induced by COBRA HA vaccines formulated with Infectimune in young and elderly ferrets. [PDF]

PLoS One
Zhang X, Thomas MH, Lynch A, Shi H, Ross TM.   +4 more
europepmc   +1 more source